SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-128812
Filing Date
2018-04-24
Accepted
2018-04-24 16:16:06
Documents
16
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 20-F d522997d20f.htm 20-F 2201021
2 EX-1.1 d522997dex11.htm EX-1.1 98925
3 EX-2.1 d522997dex21.htm EX-2.1 309539
4 EX-4.3 d522997dex43.htm EX-4.3 92421
5 EX-12.1 d522997dex121.htm EX-12.1 8915
6 EX-12.2 d522997dex122.htm EX-12.2 8993
7 EX-13.1 d522997dex131.htm EX-13.1 5226
8 EX-15.1 d522997dex151.htm EX-15.1 3232
9 GRAPHIC g522997dsp50.jpg GRAPHIC 61756
10 GRAPHIC g522997dsp53.jpg GRAPHIC 30910
11 GRAPHIC g522997dsp73.jpg GRAPHIC 12145
12 GRAPHIC g522997g13z18.jpg GRAPHIC 9315
13 GRAPHIC g522997g14a08.jpg GRAPHIC 8942
14 GRAPHIC g522997g15q81.jpg GRAPHIC 11907
15 GRAPHIC g522997g21f56.jpg GRAPHIC 11495
16 GRAPHIC g522997page0492.jpg GRAPHIC 186938
  Complete submission text file 0001193125-18-128812.txt   3189462
Mailing Address 60 AVENUE ROCKEFELLER LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38281 | Film No.: 18771613
SIC: 2836 Biological Products, (No Diagnostic Substances)